PlexBio Co., Ltd. (TPEX:6572)
5.00
-0.32 (-6.02%)
Nov 20, 2026, 2:00 PM CST
PlexBio Revenue
PlexBio had revenue of 68.75M TWD in the half year ending June 30, 2026, with 106.61% growth. This brings the company's total for the last twelve months to 137.57M, down -10.12% year-over-year. In the year 2025, PlexBio had annual revenue of 127.10M, down -0.76%. That makes PlexBio the 40,600th largest company in the world by revenue and 2,080th in Taiwan.
Revenue (ttm)
137.57M
Revenue Growth
-10.12%
P/S Ratio
3.77
Revenue / Employee
n/a
Employees
n/a
Market Cap
518.25M
Revenue by Geography
- Japan 114.85M 90.4%
- Taiwan 6.31M 5.0%
- Europe 3.75M 2.9%
- Others 1.88M 1.5%
- Mainland China 304.00K 0.2%
Fiscal year ended Dec 31, 2025 See the full PlexBio breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 127.10M | -967.00K | -0.76% |
| Dec 31, 2024 | 128.06M | -39.11M | -23.40% |
| Dec 31, 2023 | 167.18M | -24.01M | -12.56% |
| Dec 31, 2022 | 191.19M | 66.25M | 53.02% |
| Dec 31, 2021 | 124.94M | 23.60M | 23.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Rossmax International | 3.82B |
| Cowealth Medical Holding | 2.95B |
| Diamond Biotechnology | 464.63M |
| Radiant Innovation | 417.97M |
| Health & Life | 388.28M |
| EPS Bio Technology | 380.33M |
| Wiltrom | 314.12M |
| AmCad BioMed | 26.16M |